National team rider Rourke Croeser was found to be in possession of a syringe at the recent World MTB Championships in Andorra. This is in direct contravention of the UCI Medical rules and specifically in relation to the sub-section “Ban on Injections”. The possession of syringes is in violation of UCI Medical rule 13.03.058 (2). The rule states:
13.3.058 In addition to the sanctions stipulated in article 13.3.057 the following shall apply:
1. In case of infringement of article 13.3.055 all results obtained by the rider in the 48 hours period shall be disqualified.
2. In case a violation of article 13.3.052 occurs at a race the licence holder(s) concerned and, where appropriate, the whole team of the licence holder(s) at fault may be excluded from the race; in this respect the possession of objects used or fit for an injection shall be presumed to constitute evidence of a violation of article 13.3.052 having been committed except if the objects are in the possession of the medical doctor who has made the report referred to in article 13.3.052.5 and are covered by such report and except for those objects that may reasonably be in a medical doctor’s possession. The exclusion may be decided by the president of the commissaires’ panel after having given the persons concerned the opportunity to be heard or by the president of the UCI Disciplinary Commission upon report by the president of the commissaires’ panel.
Mr. Croeser voluntarily withdrew from the Championships. The matter is now being dealt with by Cycling South Africa according to the prescribed UCI rules.
William Newman, President of Cycling SA, re-iterated that the National Federation will continue to strive to ensure that riders are aware of the UCI medical rules. Cycling SA will not tolerate any activities by athletes that may be an infringement of UCI medical or anti-doping regulations.
Adriaan Davel 
From a quick google.
http://www.ekfdiagnostics.com/Hemoglobin_Analysers_114.aspx
Hemo Control is a robust hemoglobin analyser designed to provide quantitative, lab quality results (imprecision of less than 2%) within 25 seconds for blood banks, hospitals and clinics. And also, thanks to its integrated rechargeable battery, it is the perfect analyser for use in the field. Which is why you will find Hemo Control (sold as HemoPoint H2 in the USA) used in anemia screening programmes in some of the world's most challenging environments.
The range also includes the Hemo Control Manager which provides bar coded identification of patients, operators, controls and cuvettes and Hemo Vet for veterinary use.
STAT-Site is a hand-held hemoglobin analyser that combines low cost per test with portability. It is especially suited to blood screening programmes in developing world markets but also has a niche in settings where operators are mobile.
UltraCrit is a high accuracy hematocrit measurement device for blood donor screening, It is the first and only hematocrit/hemoglobin measurement device to use ultrasound technology. UltraCrit has shown an accuracy of ≤0.4%.
HemataSTAT can quickly measure hemotocrit in any setting.
The HemataSTAT® is a microhematocrit system. It provides quantitative hematocrit. The hematocrit method measures the amount of red blood cells in relation to the amount of plasma. HemataSTAT® is also perfect for veterinary use
The DiaSpect Hemoglobin T and its hand held counterpart DiaSpect Tm are the world’s fastest Hemoglobin measurement systems with laboratory quality performance for anemia screening in any environment, with results in 1-2 seconds.